FY2026 Earnings Forecast for Harrow Issued By William Blair

Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities researchers at William Blair lowered their FY2026 EPS estimates for Harrow in a research note issued to investors on Monday, July 14th. William Blair analyst L. Hanbury-Brown now expects that the company will earn $1.30 per share for the year, down from their previous estimate of $1.35. William Blair has a "Outperform" rating on the stock. The consensus estimate for Harrow's current full-year earnings is ($0.53) per share.

Several other research firms have also commented on HROW. Cantor Fitzgerald started coverage on shares of Harrow in a report on Friday, July 11th. They issued an "overweight" rating and a $76.00 price target on the stock. BTIG Research assumed coverage on Harrow in a research note on Thursday, June 12th. They issued a "buy" rating and a $62.00 price target for the company. HC Wainwright lifted their price target on Harrow from $57.00 to $60.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Finally, B. Riley reduced their price target on shares of Harrow from $69.00 to $65.00 and set a "buy" rating for the company in a research report on Tuesday, April 1st. Seven equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $63.83.

Harrow Price Performance

NASDAQ:HROW remained flat at $36.14 during mid-day trading on Tuesday. 308,261 shares of the company's stock traded hands, compared to its average volume of 499,001. Harrow has a one year low of $20.85 and a one year high of $59.23. The company has a current ratio of 0.91, a quick ratio of 0.85 and a debt-to-equity ratio of 2.01. The company has a market capitalization of $1.33 billion, a PE ratio of -64.59 and a beta of 0.41. The business's 50-day moving average price is $29.90 and its two-hundred day moving average price is $28.86.

Harrow (NASDAQ:HROW - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.40). Harrow had a negative net margin of 10.19% and a negative return on equity of 25.01%. The business had revenue of $47.83 million during the quarter, compared to analysts' expectations of $57.00 million.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Woodmont Investment Counsel LLC raised its position in shares of Harrow by 0.5% during the 4th quarter. Woodmont Investment Counsel LLC now owns 81,400 shares of the company's stock worth $2,731,000 after purchasing an additional 445 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Harrow by 3.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,356 shares of the company's stock valued at $582,000 after acquiring an additional 585 shares during the last quarter. Swiss National Bank raised its holdings in Harrow by 1.0% in the 4th quarter. Swiss National Bank now owns 59,300 shares of the company's stock valued at $1,990,000 after acquiring an additional 600 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in Harrow in the 4th quarter valued at about $25,000. Finally, MetLife Investment Management LLC raised its holdings in Harrow by 5.7% in the 4th quarter. MetLife Investment Management LLC now owns 18,908 shares of the company's stock valued at $634,000 after acquiring an additional 1,026 shares during the last quarter. Institutional investors and hedge funds own 72.76% of the company's stock.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.